Kitsap Provider Resources

Kitsap Respiratory Illness Report: Jan. 7 to Jan. 13

Click here to access week 2 of the Kitsap Respiratory Illness Report. In the week ending Jan. 13, local indicators for influenza and RSV remained high, and COVID-19 remained elevated. Statewide, RSV activity appears to be declining. 2.8% of emergency department (ED) visits were attributable to COVID-19, 1.3% were attributable to influenza, and 1.1% were attributable to Kitsap Respiratory Illness Report: Jan. 7 to Jan. 13

Kitsap Respiratory Illness Report: Dec. 31 to Jan. 6

Click here to access week 1 of the Kitsap Respiratory Illness Report. In the week ending Jan. 6, local indicators for influenza and RSV remained high, but RSV activity appears to be dropping. COVID-19 remains elevated. 2.3% of emergency department (ED) visits were attributable to COVID-19, 1.3% were attributable to influenza, and 1.1% were attributable to Kitsap Respiratory Illness Report: Dec. 31 to Jan. 6

Kitsap Respiratory Illness Report: Dec. 24 to Dec. 30

Click here to access week 52 of the Kitsap Respiratory Illness Report. In week ending Dec. 30, indicators for all three monitored respiratory viruses (COVID-19, influenza and RSV) went up, showing increasing circulation in Kitsap County. RSV and influenza indicators are currently high, and COVID-19 indicators are elevated. 2.2% of emergency department (ED) visits were attributable Kitsap Respiratory Illness Report: Dec. 24 to Dec. 30

Health Advisory: Buprenorphine and controlled substances prescribing

ACTIONS REQUESTED BE AWARE the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Drug Enforcement Agency (DEA) announced the elimination of the requirement for prescribers to have a DATA 2000 (X) waiver to prescribe buprenorphine. BE AWARE of training requirements after June 27, 2023. New or renewed DEA registrants must have eight hours of training on treatment and management Health Advisory: Buprenorphine and controlled substances prescribing

Health Advisory: Test perinatally exposed children for Hepatitis C

ACTIONS REQUESTED  BE AWARE that Centers for Disease Control and Prevention (CDC) recommends that providers test children born to people with:  TEST perinatally exposed children between the ages of 2-6 months (up to 17 months) old with an HCV RNA test. Do not test children less than 18 months old for HCV antibodies (anti-HCV). Testing for HCV antibodies (anti-HCV) in children less Health Advisory: Test perinatally exposed children for Hepatitis C

Kitsap Respiratory Illness Report: Dec. 17 to Dec. 23

Click here to access week 51 of the Kitsap Respiratory Illness Report. In week ending Dec. 23, RSV indicators in Kitsap County remained high. Influenza indicators remain elevated, and COVID-19 activity remains low; indicators for both influenza and COVID-19 have risen in the past week. 1.8% of emergency department (ED) visits were attributable to COVID-19, 1.0% Kitsap Respiratory Illness Report: Dec. 17 to Dec. 23

Kitsap Respiratory Illness Report: Dec. 10 to Dec. 16

Click here to access week 50 of the Kitsap Respiratory Illness Report. In the week ending Dec. 16, RSV indicators in Kitsap County remained high but have begun to decrease. Influenza indicators remain elevated, and COVID-19 activity remains low. 1.9% of emergency department (ED) visits were attributable to COVID-19, 1.1% were attributable to influenza, and 0.8% Kitsap Respiratory Illness Report: Dec. 10 to Dec. 16

Health Advisory: Urgent need to increase immunization coverage for influenza, COVID-19, and RSV and use of authorized/approved therapeutics in the setting of increased respiratory disease activity during the 2023-24 winter

Dec. 19, 2023 The CDC released a Health Alert on Dec. 14, 2023 to alert healthcare providers to low vaccination rates against influenza, COVID-19, and RSV (respiratory syncytial virus). See the background section below for details.   ACTIONS REQUESTED  BE AWARE that low vaccination rates, coupled with ongoing increases in local, national, and international respiratory disease activity caused by multiple pathogens, Health Advisory: Urgent need to increase immunization coverage for influenza, COVID-19, and RSV and use of authorized/approved therapeutics in the setting of increased respiratory disease activity during the 2023-24 winter

Kitsap Respiratory Illness Report: Dec. 3 to Dec. 9

Click here to access week 49 of the Kitsap Respiratory Illness Report. In week ending Dec. 9, RSV indicators in Kitsap County remained high, and influenza indicators were elevated and rising.  COVID-19 activity remains low. There was one laboratory-confirmed influenza-associated death, which occurred during the past week. 1.5% of emergency department (ED) visits were attributable to COVID-19, 1.2% were attributable Kitsap Respiratory Illness Report: Dec. 3 to Dec. 9

HAN: Mpox caused by human-to-human transmission of Monkeypox virus with geographic spread in the Democratic Republic of Congo

Distributed via the CDC Health Alert Network (HAN) on Dec. 7, 2023 The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and health departments about the occurrence, geographic spread, and sexually associated human-to-human transmission of Clade I Monkeypox virus (MPXV) in the Democratic Republic HAN: Mpox caused by human-to-human transmission of Monkeypox virus with geographic spread in the Democratic Republic of Congo